Biopeptek Pharmaceuticals LLC

Your reliable peptides partner.

610-643-4881
Request A Quote
Menu
  • Home
  • Products & Services
      • Peptide APIs
      • Research Peptides
      • Catalog Peptides
      • cGMP Peptide Manufacturing
      • Full Service CDMO
    • Close
  • Peptide Resources
    • Peptide Handling
      • Dissolving Charged Peptides
      • Dissolving Peptides
      • Dissolving Uncharged Peptides
      • Lyophilized Peptides Storage
      • Peptide Solubility
      • Peptide Stability and Degradation
    • Peptide Modifications
      • Antibody Modifications
      • Disulfide Bridges/Bonds
      • Fluorescent Modifications
      • Peptide Cyclization
      • Standard Modifications
    • Fluorophore Properties
    • Design Peptide Antigen
    • RNA Codon Table
    • FAQs
    • Close
  • About Biopeptek
    • Who we are
    • Management Team
    • Events
    • Careers
    • Close
  • Contact Us
    • Close
Home / Products & Services / Research Peptides / Pegylated Peptide
Request A Quote

Products & Services

  • Peptide APIs
  • cGMP Peptide Manufacturing
    • Quality Assurance
  • Full Service CDMO
  • Research Peptides
    • C-Terminal Modifications
    • Conjugation/Carriers
    • Cyclic Custom Peptides
    • Disulfide Bridges
    • Fluorescence/Dye Peptide Modifications
    • FRET Peptide
    • Hydrophobic Peptide
    • Isotopic Labeling
    • Lactam Bridges
    • Methylated Peptide
    • Multi-Armed Peptide (MAP)
    • N-Terminal Modifications
    • Other Amino Acid Modifications
    • Pegylated Peptide
    • Small Protein Synthesis
    • Special Amino Acids
  • Catalog Peptides

Pegylated Peptide

Pegylation is the process of covalent attachment of polyethylene glycol (PEG) polymer chains to another molecule, normally a drug or therapeutic peptide or protein. Pegylation is routinely achieved by incubation of a reactive derivative of PEG with the target macromolecule.

The covalent attachment of PEG to a drug or therapeutic peptide or protein can “mask” the agent from the host’s immune system (reduced immunogenicity and antigenicity), increase the hydrodynamic size (size in solution) of the agent which prolongs its circulatory time by reducing renal clearance. Pegylation can also provide water solubility to hydrophobic drugs and peptide synthesis or proteins.

Home / Products & Services / Research Peptides / Pegylated Peptide
Request A Quote

Biopeptek Pharmaceuticals LLC

  • 5 Great Valley Parkway, Suite 100 Malvern, PA 19355
  • (610) 643-4881
  • info@biopeptek.com

Quick Links

  • Products & Services
  • Peptide Resources
  • About
  • Press Releases
  • Events
  • Contact

Stay Connected


Sign up to receive news and updates.

Copyright © 2023 · Biopeptek Pharmaceuticals LLC. All rights reserved

Biopeptek Pharmaceuticals LLC
  • Home
  • Products & Services
    ▼
    • [Column]
      ▼
      • Peptide APIs
      • Research Peptides
      • Catalog Peptides
    • [Column]
      ▼
      • cGMP Peptide Manufacturing
      • Full Service CDMO
  • Peptide Resources
    ▼
    • Peptide Handling
      ▼
      • Dissolving Charged Peptides
      • Dissolving Peptides
      • Dissolving Uncharged Peptides
      • Lyophilized Peptides Storage
      • Peptide Solubility
      • Peptide Stability and Degradation
    • Peptide Modifications
      ▼
      • Antibody Modifications
      • Disulfide Bridges/Bonds
      • Fluorescent Modifications
      • Peptide Cyclization
      • Standard Modifications
    • Fluorophore Properties
    • Design Peptide Antigen
    • RNA Codon Table
    • FAQs
  • About Biopeptek
    ▼
    • Who we are
    • Management Team
    • Events
    • Careers
  • Contact Us
  • Search
    ▼
    • [Custom]